These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 6610070)

  • 21. Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype.
    Barsky SH; Sternlicht MD; Safarians S; Nguyen M; Chin K; Stewart SD; Hiti AL; Gray JW
    Oncogene; 1997 Oct; 15(17):2077-91. PubMed ID: 9366525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
    Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
    J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes.
    Brooks DA; Beckman I; Bradley J; McNamara PJ; Thomas ME; Zola H
    Clin Exp Immunol; 1980 Feb; 39(2):477-85. PubMed ID: 6966995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of antibody response in different immunoglobulin classes. V. Establishment of T hybrid cell line secreting IgE class-specific suppressor factor.
    Watanabe T; Kimoto M; Maruyama S; Kishimoto T; Yamamura Y
    J Immunol; 1978 Nov; 121(5):2113-7. PubMed ID: 309489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell hybrids. III. Low tumorigenicity of hybrid cells derived from fusion of high tumorigenic (BW5147 X EL-4R) cell lines.
    Bubeník J; Símová J
    Folia Biol (Praha); 1982; 28(4):274-9. PubMed ID: 6982835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between tumorigenicity and the dosage of lymphoma- vs. normal-parent-derived chromosome 15 in somatic cell hybrids between lymphoma cells with rearranged pvt-1 gene and normal cells.
    Uno M; Wirschubsky Z; Wiener F; Klein G
    Int J Cancer; 1989 Aug; 44(2):353-9. PubMed ID: 2788146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic complexity of glucocorticoid-induced lysis of murine T-lymphoma cells.
    Weinroth SE; MacLeod CL; Minning L; Hays EF
    Cancer Res; 1985 Oct; 45(10):4804-9. PubMed ID: 3875400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of human CD antigens, including CD1 and CD25, by human x mouse interlineage leukaemia hybrids.
    Taylor GM; Morten H; Carr T; Harrison C; Ridway J; Morris Jones P
    Immunology; 1987 Dec; 62(4):557-65. PubMed ID: 3428925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage.
    Larizza L; Schirrmacher V; Graf L; Pflüger E; Peres-Martinez M; Stöhr M
    Int J Cancer; 1984 Nov; 34(5):699-707. PubMed ID: 6500746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells.
    Tamai H; Watanabe S; Zheng R; Deguchi K; Cohen PA; Koski GK; Shu S
    Clin Immunol; 2008 Apr; 127(1):66-77. PubMed ID: 18262845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Segregation of chromosomes and DNA replication in intraspecific L X LS/BL hybrids.
    Nebola M; Spurná V; Kamenická E
    Folia Biol (Praha); 1981; 27(5):324-33. PubMed ID: 6895361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
    Tian J; Tang ZY; Ye SL; Liu YK; Lin ZY; Chen J; Xue Q
    Br J Cancer; 1999 Nov; 81(5):814-21. PubMed ID: 10555751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Somatic hybrids of normal and tumor Djzungarian hamster cells. II. Manifestation of malignancy and karyotype features of hybrid tumors].
    Kakpakova ES; Malakhova EM; Massino IuS; Pogosiants EE
    Genetika; 1980; 16(8):1380-8. PubMed ID: 6257592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and functional properties of tumor cell lines in accessory cell replacement assays.
    Walker EB; Lanier LL; Warner NL
    J Immunol; 1982 Feb; 128(2):852-9. PubMed ID: 7033383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
    Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
    Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.